Further Evidence of Association of OPRD1 & HTR1D Polymorphisms with Susceptibility to Anorexia Nervosa

Biological Psychiatry

Volumn 61, Issue 3, 2007, Pages 367-373

  Brown, Kirsty M O ^a   Bujac, Sarah R ^b   Mann, Evleen T ^c   Campbell, David A ^d   Stubbins, Michael J ^b   Blundell, John E ^e  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c SEACROFT HOSPITAL   (United Kingdom)

^d Catenion Strategies   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Anorexia nervosa; association; gene; opioid; serotonin; susceptibility

Indexed keywords

ADULT; ANOREXIA NERVOSA; ARTICLE; BINGE EATING DISORDER; BODY MASS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; OPIOID DELTA 1 RECEPTOR GENE; PRIORITY JOURNAL; SEROTONIN 1D RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ANOREXIA NERVOSA; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; GREAT BRITAIN; HUMANS; LINKAGE DISEQUILIBRIUM; ODDS RATIO; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, OPIOID, DELTA;

EID: 33846378438     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.04.007     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition DSM-IV (1994), American Psychiatric Press, Washington, DC
2. Bergen A.W., van den Bree M.B.M., Yeager M., Welch R., Ganjei J.K., Haque K., et al. Candidate genes for anorexia nervosa in the 1 p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Mo. Psychiatry 8 (2003) 397-406
3. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res Rev 28 (1998) 309-369
4. Blundell J.E. There a role for serotonin (5-hydroxytryptamine) in feeding. Int J Obesity 1 (1977) 15-42
5. Boeler S., Williams C., Campling G.M., Goodall E.M., and Cowen P.J. Sumatripan decreases food intake and increases plasma growth hormone in healthy women. Psychopharmacology (Berl) 129 2 (1997) 179-182
6. Brambilla F. Social stress in anorexia nervosa: a review of immuno-endocrine relationships. Physiol Behav 73 (2001) 365-369
7. Bulik C.M., Sullivan P.F., Fear J., and Pickering A. Predictors of the development of bulimia nervosa in women with anorexia nervosa. J Nerv Ment Dis 185 (1997) 704-707
8. Davis C., and Woodside D.B. Sensitivity to the rewarding effects of food and exercise in the eating disorders. Compr Psychiatry 43 (2002) 189-194
9. Drewnowski A., Shrager E.E., Lipsky C., Stellar E., and Greenwood M.R.C. Sugar and Fat - Sensory and Hedonic Evaluation of Liquid and Solid Foods. Physiol Behav 45 (1989) 177-183
10. Eckert E.D., Halmi K., Marchi P., Grove W., and Crosby R. Ten-year follow-up of anorexia nervosa: Clinical course and outcome. Psychol Med 25 (1995) 143-156
11. Eddy K.T., Keel P.K., Dorer D.J., Delinsky S.S., Franko D.L., and Herzog D.B. Longitudinal comparison of anorexia nervosa subtypes. Int J Eat Disord 31 (2002) 191-201
12. 2A promoter polymorphism -14385G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet 351 (1998) 1785-1786
13. Fairburn C.G., Cowen P.J., and Harrison P.J. Twins studies and the etiology of eating disorders. Int J Eat Disord 26 (1999) 349-358
14. Fichter M.M., Elton M., Engel K., Meyer A., Poutstka F., Mall H., et al. The Structured Interview for Anorexia and Bulimia Nervosa (SIAB): Development and characteristics of a (semi-) standardized instrument. In: Fichter M.M. (Ed). Bulimia nervosa: Basic research, diagnosis, and therapy (1989), Wiley, New York 55-70
15. Frank G.K., Kaye W.H., Meltzer C.C., Price J.C., Greer P., McConaha C., et al. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol Psychiatry 52 (2002) 896-906
16. Frank G.K., Kaye W.H., Sahu A., Fernstrom J., and McConaha C. Could reduced cerebrospinal fluid (csf) galanin contribute to restricted eating in anorexia nervosa?. Neuropsychopharmacology 24 (2001) 706-709
17. Grice D., Halmi K.A., Fichter M.M., Strober M., Woodside D.B., Kaplan A.S., et al. Evidence for a susceptibility gene for restricting anorexia nervosa on chromosome 1. Am J Med Genet 105 (2001) O76
18. Halford J.C.G., Harrold J.A., Lawton C.L., and Blundell J.E. Serotonin drugs effects on appetite expression and use for the treatment of obesity. Curr Drug Targets 6 (2005) 201-213
19. Halmi K.A. Anorexia nervosa; Demographic and clinical features in 94 cases. Psychosom Med 36 (1974) 18-26
20. Halmi K.A., Casper R.C., Eckert E.D., Goldberg S.C., and Davis J.M. Unique features associated with age of onset of anorexia nervosa. Psychiatry Res 1 (1979) 209-215
21. Hebebrand J., Himmelmann G.W., Heseker H., Schafer H., and Remschmidt H. Use of Percentiles for the body mass index in Anorexia Nervosa: Diagnostic, Epidemiological and therapeutic considerations. Int J Eat Disord 19 (1996) 359-369
22. Holland A.J., Hall A., Murray R., Russell G.F.M., and Crisp A.H. Anorexia Nervosa: A study of 34 Twin Pairs and One Set of Triplets. Br J Psychiatry 145 (1984) 414-419
23. Holland A.J., Sicotte N., and Treasure J. Anorexia Nervosa: Evidence for a Genetic Basis. J Psychosom Res 32 (1988) 561-571
24. Kaye W.H. Neuropeptide abnormalities in anorexia nervosa. Psychiatry Research 62 (1996) 65-74
25. Kaye W.H. Anorexia nervosa, obsessional behaviour, and serotonin. Psychopharmacol Bull 51 (1997) 299-313
26. Kaye W.H., Berrettini W.H., Gwirtsman H.E., Chretien M., Gold P.W., George D.T., et al. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa. Life Sci 41 (1987) 2147-2155
27. Kaye W.H., Lilenfield L.R., Berrettini W.H., Strober M., Devlin B., Klump K.L., et al. A search for susceptibility loci for Anorexia Nervosa: Methods and sample description. Biol Psychiatry 47 (2000) 794-803
28. Kirkham T.C., and Cooper S.J. Attenuation of Sham Feeding by Naloxone Is Stereospecific-Evidence for Opioid Mediation of Orosensory Reward. Physiol Behav 43 (1988) 845-847
29. Knutson B., Wolkowitz O.M., Cole S.W., Chan T., Moore E.A., Johnson R.C., et al. Selective alteration of personality and social behviour by serotonergic intervention. Am J Psychiatry 155 (1998) 373-379
30. Mehta C.R., and Patel N.R. A network Algorithm for performing Fisher's Exact Test in r x c Contingency Tables. J Am Stat Assoc 78 (1983) 427-434
31. O'Dwyer A.M., Lucey J.V., and Russell G.F. Serotonin activity in anorexia nervosa after long-term weight restoration: responses to D-fenflyramine challenge. Psychol Med 26 (1996) 353-359
32. Peciña S., and Berridge K.C. Opiod site in nucleus accumbens shell mediates eating and hedonic 'liking' for food: map based on microinjection Fos plumes. Brain Res 863 (2000) 71-86
33. Sakuta R., Tazoe M., Narita N., Narita M., Okado N., and Nagai T. Decreased serotonin level in patients with anorexia nervosa. Brain Dev 33 (2001) 76-77
34. Samarghandian S., Ohata H., Yamauchi N., and Shibasaki T. Corticotropin-releasing factor as well as opioid and dopamine are involved in tail-pinch-induced food intake of rats. Neurosci 116 (2003) 519-524
35. Srinvasagam N.M., Kaye W.H., Plotnicov K.H., Greeno C.G., Weltzin T.E., and Rao R. Persistent perfectionism, symmetry, and exactness after long-term recovery from anorexia nervos. Am J Psychiatry 152 (1995) 1630-1634
36. Strober M., Freeman R., and Morrell W. The long-term course of severe anorexia nervosa in adolescents: Survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study. Int J Eat Disord 22 (1997) 339-360
37. Sullivan P.F. Mortality in anorexia nervosa. Am J Psychiatry 152 (1995) 1073-1074
38. Taylor J.D., Briley D., Nguyen Q., Long K., Iannone M.A., Li M.S., et al. Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques 30 (2001) 661-666
39. Van Ree J.M., Niesink R.J., Van Wolfswinkel L., Ramsey N.F., Kornet M.M., Van Furth W.R., et al. Endogenous opioids and reward. Eur J Pharmacol 405 (2000) 89-101
40. Weiss K.M., and Clark A.G. Linkage disequilibrium and the mapping of complex human traits. Trends Genet 18 (2002) 19-24
41. Yeomans M.R., Wright P., Macleod H.A., and Critchley J. Effects of nalmefene on feeding in humans-dissociation of hunger and palatability. Psychopharmacol 100 (1990) 426-432
42. Zaykin D.V., Zhivotovsky L.A., and Weir B.S. Exact tests for association between alleles at arbitrary numbers of loci. Genetica 96 (1995) 169-178